REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmicell Co.,Ltd. (South Korea)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing | Soap, Cleaning Compound, and Toilet Preparation Manufacturing
Full name: Pharmicell Co.,Ltd. Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharmicell Co.,Ltd. is engaged in manufacturing of biopharmaceutical medicines used in curing diseases including cancer, brain, heart diseases and nervous system disorder. The company operates in four business divisions: Stem Cell area is engaged in manufacturing cell therapeutics and stem cell therapeutics ; Bio-based area is engaged in conducting stem cell research; Chemical area is engaged in manufacturing nucleosides, mPEGs, flame retardants, intermediates including TPC, BPDO, IDB-BPD, Carbapenem intermediates, among others; and Cosmetics area is engaged in manufacturing beauty products including counter aging solution, counter aging cream, toner, eye-cream, emulsions, and others. Pharmicell Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1968 formerly known as FCB Twelve Co., Ltd.

Headquarters
15F, Cheongho Bldg, 120 Dosan-Daero, Gangnam-Gu
Seoul; Seoul; Postal Code: 135-010

Contact Details: Purchase the Pharmicell Co.,Ltd. report to view the information.

Website: http://www.fcb12.com

Basic Information
Total Employees:
Purchase the Pharmicell Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Pharmicell Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Pharmicell Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Pharmicell Co.,Ltd. report to view the information.
Incorporation Date:
August 20, 1968
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
12.44%
Purchase this report to view the information.
0.52%
Purchase this report to view the information.
0.12%
Purchase this report to view the information.
0.01%
Purchase this report to view the information.
0.01%
Subsidiaries
Yuhwa Japan
94.5%
Yuhwa Tourism
90%
Han Kuk Shot & Machinery
82%
Company Performance
Financial values in the chart are available after Pharmicell Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-10.85%
Total operating revenue
-12.53%
Operating profit (EBIT)
-72%
EBITDA
-53.87%
Net Profit (Loss) for the Period
-78.76%
Total assets
-10.18%
Total equity
-0.52%
Operating Profit Margin (ROS)
-18.95%
Net Profit Margin
-17.43%
Return on Equity (ROE)
-10.52%
Debt to Equity Ratio
-18.31%
Quick Ratio
-0.04%
Cash Ratio
0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?